Skip to content
NeuraLight logo — Digitizing Neurology

NeuraLight

Digitizing Neurology

Founded 2021 Israel Israel 40 employees Series A Total: $30.50M Health Care, Health and Wellness

General Information

Company Name NeuraLight
Founded Year 2021
Location Israel Israel
Founders / Decision Makers
Team member Team member
Employees 40
Industries Health Care, Health and Wellness
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with NeuraLight. To contact NeuraLight, visit neuralight.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NeuraLight compare?

A PDF of NeuraLight and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NeuraLight soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NeuraLight

NeuraLight, a health care startup founded in 2021 and headquartered in Israel, is making waves with its mission to digitize neurology. The company's slogan "Digitizing Neurology" captures its innovative approach to developing a software-based platform for eye movement analysis. This platform serves as an objective and sensitive tool in the realm of neurodegenerative diseases. One of the standout achievements of NeuraLight is the successful utilization of its platform in several CNS clinical trials. These trials have demonstrated the platform's efficacy in utilizing eye movement analysis to differentiate patients from healthy subjects, stratify different subgroups, and monitor disease progression. With a recent influx of funding, NeuraLight secured a significant $25.00M Series A investment on 24 May 2022. The investors contributing to this round include prominent names such as Breyer Capital, Samsung NEXT, Alumni Ventures Blockchain Fund, Koch Disruptive Ventures, VSC Ventures, Asaf Fybish, David Golan, Castor Ventures, Lily Sarafan, and Chris Mansi. NeuraLight's innovative approach, combined with its compelling success in clinical trials, positions the company as a promising player in the intersection of healthcare and technology. As the company continues to develop its platform and garner support from notable investors, it holds potential to make a significant impact in the field of neurology and neurodegenerative diseases.

Business keywords: AI-powered, digital health, neurology, clinical development, diagnostics, precision medicine, oculometrics, neurological health, video analysis, Parkinson's Disease, ALS, MS, partnership opportunities, non-invasive testing

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $25.00M 10
Breyer Capital, Samsung NEXT +8
24 May 2022
Seed Round $5.50M -
28 Oct 2021

NeuraLight Alternatives & Competitors

View All Alternatives
NeuraLight vs
EyeMove
EyeMove Russia

Online screening for Alzheimer's and Parkinson's diseases based on eye movements.

Seed
4 employees
Health Care, Health and Wellness
NeuraLight vs

Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that...

Venture round
24 employees
Biotechnology, Health Care
NeuraLight vs

A clinical stage pharmaceutical company developing innovative treatments for neurological disease.

Series C
22 employees
Biotechnology, Health Care

FAQ About NeuraLight

Digitizing Neurology
NeuraLight was founded in 2021.
NeuraLight is headquartered in Israel.
NeuraLight operates in Health Care and Health and Wellness. Its work centres on AI-powered, digital health, neurology and clinical development.
NeuraLight has approximately 40 employees.
NeuraLight has completed 2 funding rounds, raising a total of $30.50M. The latest funding stage is Series A.
Top alternatives and competitors to NeuraLight include EyeMove, APRINOIA Therapeutics, Cerebral Therapeutics, Inc., Brainstorm Cell Therapeutics, My Moves Matter. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeuraLight and EyeMove are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NeuraLight, https://bouncewatch.com/company/neuralight, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout